What Researchers Did
Researchers conducted a prospective controlled trial to compare the efficacy of radiotherapy with hyperbaric oxygen versus radiotherapy in air for head and neck cancer patients.
What They Found
There was no difference in the overall survival rate between the hyperbaric oxygen and air groups. However, the hyperbaric oxygen group showed significantly better local tumour control, particularly in smaller lesions, leading to a significantly greater need for salvage surgery in the air group. Radiation effects on normal tissue, especially laryngeal cartilage, appeared somewhat greater in the oxygen series.
What This Means for Canadian Patients
While hyperbaric oxygen may offer improved local tumor control for head and neck cancer, Canadian patients should be aware of a potential increase in radiation effects on normal tissues, such as laryngeal cartilage. Any such adjuvant therapy would require careful consideration of individual patient factors and the balance of benefits and risks in contemporary treatment protocols.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A significant limitation is that this study was conducted in 1977, meaning its findings may not fully reflect current head and neck cancer treatment protocols and technologies.